Strata Critical Medical, Inc. Stockholders Equity

Quick Answer

Strata Critical Medical, Inc. reported Stockholders Equity of $279.07 million for fiscal year 2025.

Strata Critical Medical, Inc. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $279.07M +25.7%
2024 $221.94M -5.3%
2023 $234.30M -14.6%
2022 $274.49M -5.8%
2021 $291.37M +0.0%
2021 $291.23M +5724.6%
2020 $5.00M -54.9%
2020 $11.08M +121.6%
2019 $5.00M -75.9%
2019 $20.73M
2019 $0.00 -100.0%
2018 $31.14M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 $283.00M +21.2% +26.8%
June 30, 2025 $223.10M -2.7% +1.5%
March 31, 2025 $219.73M -7.1% -1.0%
December 31, 2024 $221.94M -5.3% -5.0%
September 30, 2024 $233.50M -11.2% +1.8%
June 30, 2024 $229.39M -12.0% -3.1%
March 31, 2024 $236.61M -12.4% +1.0%
December 31, 2023 $234.30M -14.6% -10.9%
  • Strata Critical Medical, Inc. showed an increase of +25.7% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2018–2025 period, Strata Critical Medical, Inc.’s stockholders equity has grown by 796.2% (from $31.14 million to $279.07 million).
  • The most recent figure is from Strata Critical Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment